Hsu-Ping Kuo
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 3
- Cancer Mechanisms and Therapy 2
- Co-authors
- Yee Chao (1 shared paper)Kwan‐Hwa Chi (1 shared paper)Shih‐Jen Liu (1 shared paper)Chung‐Pin Li (1 shared paper)Yu‐Shan Wang (1 shared paper)Betty Y Chang (5 shared papers)Karl J. Schweighofer (4 shared papers)Karl Eckert (4 shared papers)
- Journals
- Blood (3 papers)Cancer Cell (1 paper)Molecular Carcinogenesis (1 paper)Journal of Immunotherapy (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesBelgiumTaiwan
In The Last Decade
Hsu-Ping Kuo
9 papers receiving 462 citations
Peers
Comparison fields: 5 of 38
- Pathology and Forensic Medicine 142
- Genetics 81
- Immunology 145
- Oncology 177
- Hematology 58
Countries citing papers authored by Hsu-Ping Kuo
This map shows the geographic impact of Hsu-Ping Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsu-Ping Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsu-Ping Kuo more than expected).
Fields of papers citing papers by Hsu-Ping Kuo
This network shows the impact of papers produced by Hsu-Ping Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsu-Ping Kuo. The network helps show where Hsu-Ping Kuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsu-Ping Kuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 162 | |
| 2 | 2015 | 113 | |
| 3 | 2017 | 56 | |
| 4 | 2015 | 49 | |
| 5 | The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. | 2016 | 49 |
| 6 | 2009 | 18 | |
| 7 | 2014 | 9 | |
| 8 | Glutamate-cysteine ligase catalytic subunit as a therapeutic target in acute myeloid leukemia and solid tumors. | 2021 | 8 |
| 9 | 2016 | 2 |
About Hsu-Ping Kuo
Hsu-Ping Kuo is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 466 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Mechanisms and Therapy (2 papers), Protein Degradation and Inhibitors (2 papers), Galectins and Cancer Biology (2 papers), Immune Cell Function and Interaction (2 papers), interferon and immune responses (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (142 citations), Genetics (81 citations), Immunology (145 citations), Oncology (177 citations) and Hematology (58 citations). Hsu-Ping Kuo has collaborated with scholars based in United States, Belgium and Taiwan. Frequent co-authors include Yee Chao, Kwan‐Hwa Chi, Shih‐Jen Liu, Chung‐Pin Li, Yu‐Shan Wang, Betty Y Chang, Karl J. Schweighofer, Karl Eckert, Mint Sirisawad and Leo W.K. Cheung. Their work appears in journals such as Blood, Cancer Cell, Molecular Carcinogenesis, Journal of Immunotherapy and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.